Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
5.5
-65.13%
60%
—
37.79%
Every year
—
5 Years
Score5.5
Net Growth-65.13%
Net Trend60%
Net Income Consistency—
Rev Growth37.79%
Rev TrendEvery year
Revenue Consistency—
Pacira BioSciences, Inc. fundamental performance
Between 2020 and 2025, revenue grew from $ 429M to $ 726M and net income declined from $ 145M to $ 7M. Revenue increased in every one of those 5 years; net income in 3.
Between 2015 and 2025, revenue grew from $ 248M to $ 726M and net income grew from $ 1M to $ 7M. Revenue increased in every one of those 10 years; net income in 5.
Pacira BioSciences, Inc. currently holds a 5-year HDB Score of 5.5 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 23.70 | — |
1 Year2025-08-12 | $ 24.81 | -4.47% |
5 Years2021-08-12 | $ 58.33 | -59.37% |
10 Years2016-08-12 | $ 45.51 | -47.92% |
All Time2011-02-03 | $ 7.02 | 237.61% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2011-02-03 |
|---|---|---|---|---|---|
| Price | $ 23.70 | $ 24.81 | $ 58.33 | $ 45.51 | $ 7.02 |
| Return | — | -4.47% | -59.37% | -47.92% | 237.61% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 746M | $ 14M | $ 251M |
| 2025 | $ 726M | $ 7M | $ 238M |
| 2024 | $ 700M | -$ 99M | $ 484M |
| 2023 | $ 674M | $ 41M | $ 278M |
| 2022 | $ 666M | $ 15M | $ 288M |
| 2021 | $ 541M | $ 41M | $ 656M |
| 2020 | $ 429M | $ 145M | $ 521M |
| 2019 | $ 421M | -$ 11M | $ 291M |
| 2018 | $ 337M | -$ 471K | $ 383M |
| 2017 | $ 286M | -$ 42M | $ 311M |
| 2016 | $ 276M | -$ 37M | $ 172M |
| 2015 | $ 248M | $ 1M | $ 158M |
| 2014 | $ 197M | -$ 13M | $ 158M |
| 2013 | $ 85M | -$ 63M | $ 72M |
| 2012 | $ 39M | -$ 52M | $ 42M |
| IPO2011 | $ 15M | -$ 43M | $ 76M |
Explore beyond PCRX
You're looking at Pacira BioSciences, Inc.. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
